Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SK 08

Next Previous
Drug Profile

SK 08

Alternative Names: SK-08

Latest Information Update: 28 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Zhiyi Biotechnology
  • Class Anti-inflammatories; Antineoplastics; Bacteria
  • Mechanism of Action Bacteria replacements; Microbiome modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Irritable bowel syndrome
  • Phase II Inflammatory bowel diseases
  • Phase I/II Solid tumours
  • No development reported Ulcerative colitis

Most Recent Events

  • 28 Aug 2025 No recent reports of development identified for phase-I development in Ulcerative-colitis in China (PO, Powder)
  • 09 Mar 2025 Consun Pharmaceutical initiates a phase I trial (In volunteers) in China (PO) (NCT07021157)
  • 09 Dec 2024 Guangzhou Zhiyi Biotechnology plans a phase II trial for Uncelrative colitis (Treatment experienced) in July 2025 (NCT06725017)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top